Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
about
Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapyInterventions to improve adherence to antiretroviral therapy in children with HIV infectionHIV & immune reconstitution inflammatory syndrome (IRIS)Treatment guidelines and prognosis of immune reconstitution inflammatory syndrome patients: a reviewBacterial disease and antimicrobial susceptibility patterns in HIV-infected, hospitalized children: a retrospective cohort studyDeterminants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012Predictors of Hospitalization among Children on ART in Ethiopia: a Cohort study.Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda.The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan childrenPoor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagementTrends in hospitalizations among children and young adults with perinatally acquired HIV.Timing of antiretroviral therapy for HIV in the setting of TB treatment.Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesMonitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two EpidemicsSurvival of HIV-infected children: a cohort study from the Asia-Pacific region.Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study.Cohort profile: the TREAT Asia pediatric HIV observational database.Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescentsUnder-two child mortality according to maternal HIV status in Rwanda: assessing outcomes within the National PMTCT Program.The burden of disease on HIV-infected orphaned and non-orphaned children accessing primary health facilities in a rural district with poor resources in South Africa: a cross-sectional survey of primary caregivers of HIV-infected children aged 5-18 yUnderstanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.Effect of antiretroviral therapy on clinical and immunologic disease progression in HIV positive children: One-year follow-up study.Global challenges in the development and delivery of paediatric antiretrovirals.Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in ShanghaiAIDS and drug rationingLipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of ageEarly antiretroviral therapy of HIV-infected infants in resource-limited countries: possible, feasible, effective and challengingPediatric HIV immune reconstitution inflammatory syndrome.Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in childrenEffectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia.High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectionUnderstanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation.High Viremia and Wasting Before Antiretroviral Therapy Are Associated With Pneumonia in Early-Treated HIV-Infected Kenyan Infants.Factors underlying taking a child to HIV care: implications for reducing loss to follow-up among HIV-infected and -exposed children.Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment.Risk-taking behaviors among vertically HIV-infected adolescents in northern Thailand.Morbidity and Mortality of a Cohort of Peruvian HIV-Infected Children 2003-2012.
P2860
Q21261820-6DCEC7A6-C55C-43ED-BB3E-A93BA3ECB21FQ24234320-4648BD2F-09B9-405D-AD54-3D78418ED93EQ26852805-7C0A057D-2D83-466E-9D3E-1E865F34ACB7Q28081975-4C153AAE-78A3-4A00-A076-163859D183AFQ28473645-52A25B73-4DD8-4434-B1B1-5F669496EB83Q33553629-C020B550-66A3-4F14-BEF3-295342A7A615Q33596123-54FE65D6-1DC1-489A-8E74-CFA7C26F2133Q33748141-DE0051A9-786B-401A-A9AE-2257B6117E94Q33972150-C4A1FB4D-2027-4770-AFB6-B1D76D32ADF9Q34039981-741DBA2C-106B-450C-8257-7EDAFF14A4CBQ34374033-50F11661-CEEA-4D3B-BA35-4778873C78F5Q34432664-57EFC526-8426-4B7F-9F5A-0CB7F31860FDQ34475542-725061F7-52B1-4698-BA43-20EE6AE990DDQ34513045-9AF7F289-57AF-4BB9-938E-53B50BB52839Q34734797-4FD16065-4DDF-435A-947E-13DAD7323204Q34773604-424FC3BC-F8AA-4384-912C-A437D991A7CDQ35019846-A952FA49-ED97-42F9-8BFB-7FD57FE80E4CQ35020908-DF5E26DB-D8E7-4FEA-93E9-B8518A583CACQ35338750-35350DB3-7EF7-496C-8858-8AB59BE90A5AQ35548335-CFD4C192-CA6F-40AA-8ED4-E059FD09EB11Q35580318-5FE62785-CB11-4C5B-A35A-EEFFB2627E61Q36288227-C0FBA7A9-215E-4980-8A09-B828FB97F2A1Q36449752-17C54B2D-22D2-4FAB-84C0-5DC226C032A0Q36800408-3F60B93F-FE57-40CC-A695-74D32E68D7F6Q36993017-C8A71842-C087-48BB-8B1C-97D633CF84FDQ37020927-B657D937-0BA1-49C3-8EEA-3127ABFF59DEQ37080086-F3C5C9DB-1ED7-465E-AD65-4F8116C8343BQ37111670-4976A490-AD94-4577-9854-E67263D0A296Q37187414-89E86BEC-6130-4E01-8BF7-AF40959F0C75Q37202004-F160E50A-76AE-4089-BCDA-92D102693634Q37455795-A391404C-1E08-4B8F-B5A9-72270EEC4AB5Q37461250-E0FD122E-2C56-4F03-8CD6-A5CD38E962A1Q37498812-031AABDD-AF1D-4DE9-BD7F-C5D0CAD10A60Q37696892-0455D92C-58D3-4231-BCBC-5C9DCBD271E5Q37728208-8C764DE8-561D-4E65-9F0A-ED51463D0813Q39535039-B13396AF-E09E-45EE-8EF5-300A5C989D76Q39566907-B86C022A-4C11-4DCC-921A-0772F80A21F3Q44446088-55F8228B-DB69-4648-99C4-2BD67B6C6B11Q45930159-F93815A6-0D12-4820-BC19-D4AE09C9C087Q46498877-7C4DC0EC-6D99-484A-A47F-334E1C90E21D
P2860
Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hospitalization and mortality ...... active antiretroviral therapy.
@ast
Hospitalization and mortality ...... active antiretroviral therapy.
@en
type
label
Hospitalization and mortality ...... active antiretroviral therapy.
@ast
Hospitalization and mortality ...... active antiretroviral therapy.
@en
prefLabel
Hospitalization and mortality ...... active antiretroviral therapy.
@ast
Hospitalization and mortality ...... active antiretroviral therapy.
@en
P2093
P2860
P356
P1476
Hospitalization and mortality ...... active antiretroviral therapy.
@en
P2093
Linda Aurpibul
Noppadon Akarathum
Peninnah Oberdorfer
Pornphun Wannarit
Suparat Kanjananit
Thanyawee Puthanakit
Thira Sirisanthana
Virat Sirisanthana
P2860
P304
P356
10.1086/510489
P407
P577
2007-01-09T00:00:00Z